Generic Pharmaceuticals Company Investment Opportunity in New York, United States
Generic complex injectable pharmaceutical manufacturer with 5 drugs pending approval and proven track record.
Premium Plan
| Established | 5-10 year(s) |
| Employees | 10 - 50 |
| Legal Entity | Limited Liability Company (LLC) |
| Reported Sales | Nil |
| Run Rate Sales | Nil |
| EBITDA Margin | Nil |
| Industries | Generic Pharmaceuticals |
| Locations | New York |
| Local Time | 3:02 PM US / Eastern |
| Listed By | Management Member |
| Status | Active |
Partial Stake Sale
USD
20 million
for
5.0%
stake
(Native Currency: USD 20,000,000)
Reason: Expansion of existing facility to manufacture additional drugs.
Includes physical assets worth
USD
18 million
Interested to connect with advisors
Name, Phone, Email
Available after connect
Business Name
Available after connect
User Verification
Documents
Pharma Setup
(6.3 MB)
Business Overview
- The two main partners sold their stake in a previous company almost 10 years back and have now created their own new company.
- They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months.
- The facility was inspected very recently by the FDA and passed.
- We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors.
- The company should be worth USD 2B in another 3 years.
- The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.
- They hold over 40 patents and are on the verge of their first approved generic complex injectable drug in a couple of months.
- The facility was inspected very recently by the FDA and passed.
- We have 5 drugs pending approval with a total market value of over USD 4B and only a few competitors.
- The company should be worth USD 2B in another 3 years.
- The business has not generated any revenue because we have been in the process of R&D in developing these drugs for the past 6 years and have invested over USD 40 million in the business.
Products & Services Overview
We have 5 drugs in the pipeline. Information is attached. The drugs are all generic and we are only 1 of 2/3 facilities in the United States that are able to manufacture complex injectables.
Assets Overview
Specialized equipment for the manufacturing of complex injectables. The business also owns land of 27 acres.
Facilities Overview
27 acres of own land, 50,000 sqft of building space in East Windsor.
Capitalization Overview
Friends, family, and distribution contracts.USD 4.2M - outstanding loan on the existing building.
USD 3M - 2nd deposit on specialized equipment that is being manufactured in Europe.
There are 7 shareholders in the business.
Recent Activity
-
Earlier than 15 daysOwner, Industrial Development, Mayagüez, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysChairman, Medical Supplies, London, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysPresident, Dental Clinics, Winnipeg, Corporate Investor / Buyer connected with the Business
Tags:
Generic Pharmaceuticals Company Investment Opportunity in New York, United States
·Invest in Generic Pharmaceuticals Company in New York, United States
·Generic Pharmaceuticals Company Investment Opportunity in NYC
·Generic Pharmaceuticals Company Investment Opportunity
·Investment Opportunity in New York, United States
·Invest in Generic Pharmaceuticals Company in NYC
·Invest in Generic Pharmaceuticals Company
·Invest in New York, United States
·Investment Opportunity in NYC
·Invest in NYC
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
Contact Business
7 Investors already contacted this Business.
Register below to connect now!
- Social
- Register
- Login
Who uses SMERGERS?
... and 114,500+ other businesses of all sizes.
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct.
You might also be interested in these businesses